Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
ACS Applied Materials & Interfaces|September 28, 2021
Analyzing Gamma-Ray Irradiation Effects on Carbon Nanotube Top-Gated Field-Effect TransistorsMaguang Zhu, Jianshuo Zhou, Pengkun Sun, et al.European Journal of Medicinal Chemistry|June 18, 2026
Rewiring cell death and evading repair: Evolution of temozolomide and emerging strategies against resistant glioblastomaLan Wang, Tengfei Zhen, Hui Liu, et al.RSC Medicinal Chemistry|September 21, 2023
Design, synthesis, and biological evaluation of novel pyrimidin-2-amine derivatives as potent PLK4 inhibitorsYanli Xue, Shuyi Mu, Pengkun Sun, et al.International Journal of Molecular Sciences|May 27, 2023
Identification of RNA-Binding Protein Targets with HyperTRIBE in Saccharomyces cerevisiaeWeilan Piao, Chong Li, Pengkun Sun, et al.RSC Medicinal Chemistry|June 16, 2025
Design, synthesis, and biological evaluation of novel N-(1H-indazol-6-yl)benzenesulfonamide derivatives as potent PLK4 inhibitorsPengkun Sun, Cunzheng Fan, Nian Liu, et al.ACS Nano|March 5, 2024
Wafer-Scale Carbon Nanotubes Diodes Based on Dielectric-Induced Electrostatic DopingXinyue Zhang, Pengkun Sun, Nan Wei, et al.European Journal of Medicinal Chemistry|June 20, 2025
Rational design of CZL-S092: A novel indazole-based PLK4 inhibitor targeting neuroblastoma through virtual screening and fragment-based drug design strategiesNian Liu, Ningyuan Hu, Cunzheng Fan, et al.RSC Medicinal Chemistry|August 18, 2025
Design, synthesis, and biological evaluation of 5-chlorine-2-amino-pyrimidine derivatives as potent PLK4 inhibitorsShuyi Mu, Wenqiang Sun, Zehui Qi, et al.Journal of Medicinal Chemistry|February 3, 2023
Discovery of CZS-241: A Potent, Selective, and Orally Available Polo-Like Kinase 4 Inhibitor for the Treatment of Chronic Myeloid LeukemiaYin Sun, Yanli Xue, Hongbing Liu, et al.Journal of Medicinal Chemistry|June 6, 2023
Discovery of the First Potent, Selective, andYin Sun, Yanli Xue, Pengkun Sun, et al.Pageof 2